wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28081872-74C6C3CE-4824-404A-B41A-F7B55A2F5086
Q28081872-74C6C3CE-4824-404A-B41A-F7B55A2F5086
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28081872-74C6C3CE-4824-404A-B41A-F7B55A2F5086
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
P2860
Q28081872-74C6C3CE-4824-404A-B41A-F7B55A2F5086
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28081872-74C6C3CE-4824-404A-B41A-F7B55A2F5086
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3d64ad9bbe36cf4ab536fa2432b62f27c0b4eec
P2860
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial.